Volume 14 Issue 4
Jul.  2023
Turn off MathJax
Article Contents
Chinese Society of Rare Diseases, Rare Diseases Society of Chinese Research Hospital Association, National Rare Diseases Committee, Beijing Rare Disease Diagnosis, Treatment and Protection Society. Expert Consensus for the Diagnosis and Treatment of Bartter Syndrome in China(2023)[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 744-757. doi: 10.12290/xhyxzz.2023-0207
Citation: Chinese Society of Rare Diseases, Rare Diseases Society of Chinese Research Hospital Association, National Rare Diseases Committee, Beijing Rare Disease Diagnosis, Treatment and Protection Society. Expert Consensus for the Diagnosis and Treatment of Bartter Syndrome in China(2023)[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 744-757. doi: 10.12290/xhyxzz.2023-0207

Expert Consensus for the Diagnosis and Treatment of Bartter Syndrome in China(2023)

doi: 10.12290/xhyxzz.2023-0207

National Key R & D Program of China 2022ZD0116003

National High Level Hospital Clinical Research Funding 2022-PUMCH-B-019

National High Level Hospital Clinical Research Funding 2022-PUMCH-D-002

Capital's Funds for Health Improvement and Research CFH 2020-2-4018

CAMS Innovation Fund for Medical Sciences 2021-I2M-1-003

  • Received Date: 2023-04-20
  • Accepted Date: 2023-05-15
  • Available Online: 2023-06-09
  • Publish Date: 2023-07-30
  • Bartter syndrome (BS) is a rare inherited salt-losing renal tubular disorder characterized by secondary hyperaldosteronism with hypokalemia and hypochloremic metabolic alkalosis, and normal or low blood pressure. In severe cases, preterm delivery, hypovolemia, ventricular arrhythmia, rhabdomyolysis, renal failure, growth failure and sensorineural deafness may occur. In recent years, research on BS has made significant progress. The Bartter Syndrome Consensus Working Group has performed a systematic literature review, and based on evidence-based medicine, summarized aspects related to BS, including clinical manifestations and classification, diagnosis, treatment strategies, and management of complications. This consensus provides an important reference for the better diagnosis and treatment of BS.
  • loading
  • [1] Konrad M, Nijenhuis T, Ariceta G, et al. Diagnosis and management of Bartter syndrome: executive summary of the consensus and recommendations from the European Rare Kidney Disease Reference Network Working Group for Tubular Disorders[J]. Kidney Int, 2021, 99: 324-335. doi:  10.1016/j.kint.2020.10.035
    [2] Graham AJ, Gelfand G, McFadden SD, et al. Levels of evidence and grades of recommendations in general thoracic surgery[J]. Can J Surg, 2004, 47: 461-465.
    [3] 王建祥, 张奉春, 刘晓清, 等. 中国成人血小板减少症诊疗专家共识[J]. 中华内科杂志, 2020, 59: 498-510. doi:  10.3760/cma.j.cn112138-20200424-00419
    [4] Jones J, Hunter D. Consensus methods for medical and health services research[J]. BMJ, 1995, 311: 376-380. doi:  10.1136/bmj.311.7001.376
    [5] Bamgbola OF, Ahmed Y. Differential diagnosis of perinatal Bartter, Bartter and Gitelman syndromes[J]. Clin Kidney J, 2021, 14: 36-48. doi:  10.1093/ckj/sfaa172
    [6] Seys E, Andrini O, Keck M, et al. Clinical and genetic spectrum of Bartter syndrome type 3[J]. J Am Soc Nephrol, 2017, 28: 2540-2552. doi:  10.1681/ASN.2016101057
    [7] Legrand A, Treard C, Roncelin I, et al. Prevalence of novel MAGED2 mutations in antenatal Bartter syndrome[J]. Clin J Am Soc Nephrol, 2018, 13: 242-250. doi:  10.2215/CJN.05670517
    [8] Lee HS, Cheong HI, Ki CS. A case of antenatal Bartter syndrome with sensorineural deafness[J]. J Pediatr Endocrinol Metab, 2010, 23: 1077-1081.
    [9] Finer G, Shalev H, Birk OS, et al. Transient neonatal hyperkalemia in the antenatal (ROMK defective) Bartter syndrome[J]. J Pediatr, 2003, 142: 318-323. doi:  10.1067/mpd.2003.100
    [10] Birkenhager R, Otto E, Schurmann MJ, et al. Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure[J]. Nat Genet, 2001, 29: 310-314. doi:  10.1038/ng752
    [11] Shalev H, Ohali M, Kachko L, et al. The neonatal variant of Bartter syndrome and deafness: preservation of renal function[J]. Pediatrics, 2003, 112: 628-633. doi:  10.1542/peds.112.3.628
    [12] Takemori S, Tanigaki S, Nozu K, et al. Prenatal diagnosis of MAGED2 gene mutation causing transient antenatal Bartter syndrome[J]. Eur J Med Genet, 2021, 64: 104308. doi:  10.1016/j.ejmg.2021.104308
    [13] Laghmani K, Beck BB, Yang SS, et al. Polyhydramnios, transient antenatal Bartter's syndrome, and MAGED2 mutations[J]. N Engl J Med, 2016, 374: 1853-1863. doi:  10.1056/NEJMoa1507629
    [14] 韩玥, 郎艳华, 林毅, 等. 42例3型巴特综合征CLCNKB基因变异分析和基因型/表型研究[J]. 中华肾脏病杂志, 2019, 35: 499-506. doi:  10.3760/cma.j.issn.1001-7097.2019.07.004
    [15] London S, Levine MA, Li D, et al. Hypocalcemia as the initial presentation of type 2 Bartter syndrome: a family report[J]. J Clin Endocrinol Metab, 2022, 107: 1679-1688. doi:  10.1210/clinem/dgac130
    [16] Brum S, Rueff J, Santos JR, et al. Unusual adult-onset manifestation of an attenuated Bartter's syndrome type Ⅳ renal phenotype caused by a mutation in BSND[J]. Nephrol Dial Transplant, 2007, 22: 288-289.
    [17] García Castaño A, Pérez de Nanclares G, Madariaga L, et al. Poor phenotype-genotype association in a large series of patients with Type Ⅲ Bartter syndrome[J]. PloS One, 2017, 12: e0173581. doi:  10.1371/journal.pone.0173581
    [18] Palazzo V, Raglianti V, Landini S, et al. Clinical and genetic characterization of patients with Bartter and Gitelman syndrome[J]. Int J Mol Sci, 2022, 23: 5641. doi:  10.3390/ijms23105641
    [19] 韩玥, 林毅, 孙清, 等. 中国16例巴特综合征基因变异分析和治疗随访研究[J]. 中华肾脏病杂志, 2017, 33: 573-581. doi:  10.3760/cma.j.issn.1001-7097.2017.08.003
    [20] Khandelwal P, Sabanadesan J, Sinha A, et al. Isolated nephrocalcinosis due to compound heterozygous mutations in renal outer medullary potassium channel[J]. CEN Case Rep, 2020, 9: 232-236. doi:  10.1007/s13730-020-00464-y
    [21] 王小娟, 陈琛, 杜婷婷, 等. 成年Ⅲ型Bartter综合征1例并文献复习[J]. 内科急危重症杂志, 2016, 22: 62-63. https://www.cnki.com.cn/Article/CJFDTOTAL-NKJW201601026.htm
    [22] 于迎, 潘晓霞, 任红, 等. 成人经典型Bartter综合征家系CLCNKB基因变异的研究[J]. 中华肾脏病杂志, 2010, 26: 598-602. doi:  10.3760/cma.j.issn.1001-7097.2010.08.007
    [23] 韩玥, 王芳, 王彦刚, 等. 成年发病的2型巴特综合征1例[J]. 中华内科杂志, 2017, 56: 679-680. doi:  10.3760/cma.j.issn.0578-1426.2017.09.012
    [24] Huang L, Luiken GP, van Riemsdijk IC, et al. Nephrocalcinosis as adult presentation of Bartter syndrome type Ⅱ[J]. Neth J Med, 2014, 72: 91-93.
    [25] Kleta R, Bockenhauer D. Salt-losing tubulopathies in children: what's new, what's controversial?[J]. J Am Soc Nephrol, 2018, 29: 727-739. doi:  10.1681/ASN.2017060600
    [26] Malafronte C, Borsa N, Tedeschi S, et al. Cardiac arrhythmias due to severe hypokalemia in a patient with classic Bartter disease[J]. Pediatr Nephrol, 2004, 19: 1413-1415. doi:  10.1007/s00467-004-1611-0
    [27] Cortesi C, Bettinelli A, Emma F, et al. Severe syncope and sudden death in children with inborn salt-losing hypokalaemic tubulopathies[J]. Nephrol Dial Transplant, 2005, 20: 1981-1983. doi:  10.1093/ndt/gfh893
    [28] Zanolari Calderari M, Vigier RO, Bettinelli A, et al. Electrocardiographic QT prolongation and sudden death in renal hypokalemic alkalosis[J]. Nephron, 2002, 91: 762-763. doi:  10.1159/000065045
    [29] Cortesi C, Lava SA, Bettinelli A, et al. Cardiac arrhythmias and rhabdomyolysis in Bartter-Gitelman patients[J]. Pediatr Nephrol, 2010, 25: 2005-2008. doi:  10.1007/s00467-010-1580-4
    [30] Blanchard A, Bockenhauer D, Bolignano D, et al. Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference[J]. Kidney Int, 2017, 91: 24-33. doi:  10.1016/j.kint.2016.09.046
    [31] 刘帆, 孙妍, 徐潮, 等. 低钾血症中遗传性肾小管疾病的临床特点分析[J]. 临床荟萃, 2021, 36: 436-441. doi:  10.3969/j.issn.1004-583X.2021.05.010
    [32] Walsh PR, Tse Y, Ashton E, et al. Clinical and diagnostic features of Bartter and Gitelman syndromes[J]. Clin Kidney J, 2018, 11: 302-309. doi:  10.1093/ckj/sfx118
    [33] 韩玥, 郎艳华, 肖淑佼, 等. 中国5例2型巴特综合征KCNJ1基因变异分析和临床表型研究[J]. 中华肾脏病杂志, 2020, 36: 115-122. doi:  10.3760/cma.j.issn.1001-7097.2020.02.008
    [34] Bettinelli A, Borsa N, Bellantuono R, et al. Patients with biallelic mutations in the chloride channel gene CLCNKB: long-term management and outcome[J]. Am J Kidney Dis, 2007, 49: 91-98. doi:  10.1053/j.ajkd.2006.10.001
    [35] Scognamiglio R, Negut C, Calò LA. Aborted sudden cardiac death in two patients with Bartter's/Gitelman's syndromes[J]. Clin Nephrol, 2007, 67: 193-197. doi:  10.5414/CNP67193
    [36] Maruyama H, Shinno Y, Fujiwara K, et al. Nephrocal-cinosis and placental findings in neonatal bartter syndrome[J]. AJP Rep, 2013, 3: 21-24.
    [37] Brochard K, Boyer O, Blanchard A, et al. Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome[J]. Nephrol Dial Transplant, 2009, 24: 1455-1464. doi:  10.1093/ndt/gfn689
    [38] 李新岩, 姜艳, 许莉军, 等. KCNJ1新的复合杂合变异致Bartter综合征Ⅱ型临床和遗传分析[J]. 中华内科杂志, 2017, 56: 760-762. doi:  10.3760/cma.j.issn.0578-1426.2017.10.010
    [39] Yamazaki H, Nozu K, Narita I, et al. Atypical phenotype of type Ⅰ Bartter syndrome accompanied by focal segmental glomerulosclerosis[J]. Pediatr Nephrol, 2009, 24: 415-418. doi:  10.1007/s00467-008-0999-3
    [40] Adachi M, Tajima T, Muroya K, et al. Classic Bartter syndrome complicated with profound growth hormone deficiency: a case report[J]. J Med Case Rep, 2013, 7: 283. doi:  10.1186/1752-1947-7-283
    [41] Garnier ADS, Vargas-Poussou R, Oury JF, et al. Bartter syndrome prenatal diagnosis based on amniotic fluid biochemical analysis[J]. Pediatr Res, 2010, 67: 300-303. doi:  10.1203/PDR.0b013e3181ca038d
    [42] Allaf B, Dreux S, Schmitz T, et al. Amniotic fluid biochemistry in isolated polyhydramnios: a series of 464 cases[J]. Prenat Diagn, 2015, 35: 1331-1335. doi:  10.1002/pd.4700
    [43] 中国研究型医院学会罕见病分会, 中国罕见病联盟, 北京罕见病诊疗与保障学会, 等. Gitelman综合征诊疗中国专家共识(2021版)[J]. 协和医学杂志, 2021, 12: 902-912. doi:  10.12290/xhyxzz.2021-0555
    [44] Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17: 405-424. doi:  10.1038/gim.2015.30
    [45] Marcoux AA, Slimani S, Tremblay LE, et al. Endocytic recycling of Na(+) -K(+) -Cl(-) cotransporter type 2: importance of exon 4[J]. J Physiol, 2019, 597: 4263-4276. doi:  10.1113/JP278024
    [46] Marcoux AA, Slimani S, Tremblay LE, et al. Regulation of Na(+)-K(+)-Cl(-) cotransporter type 2 by the with no lysine kinase-dependent signaling pathway[J]. Am J Physiol Cell Physiol, 2019, 317: 20-30. doi:  10.1152/ajpcell.00041.2019
    [47] 彭晓艳, 蒋兰萍, 袁涛, 等. 氯离子清除试验在Gitelman综合征鉴别诊断中的应用[J]. 中国医学科学院学报, 2016, 38: 275-282. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYKX201603006.htm
    [48] Nozu K, Iijima K, Kanda K, et al. The pharmacological characteristics of molecular-based inherited salt-losing tubulopathies[J]. J Clin Endocrinol Metab, 2010, 95: 511-518. doi:  10.1210/jc.2010-0392
    [49] Colussi G, Bettinelli A, Tedeschi S, et al. A thiazide test for the diagnosis of renal tubular hypokalemic disorders[J]. Clin J Am Soc Nephrol, 2007, 2: 454-460. doi:  10.2215/CJN.02950906
    [50] Nam G, Cho A, Park MH. A rare cause of refractory severe polyhydramnios: antenatal Bartter syndrome[J]. Medicina, 2021, 57: 272. doi:  10.3390/medicina57030272
    [51] Dane B, Dane C, Aksoy F, et al. Antenatal Bartter syndrome: analysis of two cases with placental findings[J]. Fetal Pediatr Pathol, 2010, 29: 121-126. doi:  10.3109/15513811003777276
    [52] Bhat YR, Vinayaka G, Vani R, et al. Antenatal Bartter syndrome: a rare cause of unexplained severe polyhydra-mnios[J]. Ann Trop Paediatr, 2013, 31: 153-157.
    [53] Mani S, Nair J, Handa D. Antenatal Bartter syndrome: a new compound heterozygous mutation in exon 2 of KCNJ1 gene[J]. BMJ Case Rep, 2021, 14: e244685. doi:  10.1136/bcr-2021-244685
    [54] Francini F, Gobbi L, Ravarotto V, et al. The dietary approach to the treatment of the rare genetic tubulopathies Gitelman's and Bartter's syndromes[J]. Nutrients, 2021, 13: 2960. doi:  10.3390/nu13092960
    [55] Han Y, Cheng H, Shao S, et al. Thirteen novel CLCNKB variants and genotype/phenotype association study in 42 Chinese patients with Bartter syndrome type 3[J]. Endocrine, 2020, 68: 192-202. doi:  10.1007/s12020-019-02156-9
    [56] Gasongo G, Greenbaum LA, Niel O, et al. Effect of nonsteroidal anti-inflammatory drugs in children with Bartter syndrome[J]. Pediatr Nephrol, 2019, 34: 679-684. doi:  10.1007/s00467-018-4135-8
    [57] Plumb LA, Van't Hoff W, Kleta R, et al. Renal apnoea: extreme disturbance of homoeostasis in a child with Bartter syndrome type Ⅳ[J]. Lancet, 2016, 388: 631-632. doi:  10.1016/S0140-6736(16)00087-8
    [58] Zaffanello M, Taranta A, Palma A, et al. Type Ⅳ Bartter syndrome: report of two new cases[J]. Pediatr Nephrol, 2006, 21: 766-770. doi:  10.1007/s00467-006-0090-x
    [59] 韩玥, 郎艳华, 林毅, 等. 中国4例4a型巴特综合征BSND基因变异和临床表型分析[J]. 中华肾脏病杂志, 2021, 37: 851-853. doi:  10.3760/cma.j.cn441217-20200915-00129
    [60] Adachi M, Asakura Y, Sato Y, et al. Novel SLC12A1 (NKCC2) mutations in two families with Bartter syndrome type 1[J]. Endocr J, 2007, 54: 1003-1007. doi:  10.1507/endocrj.K06-204
    [61] Nagao R, Suzuki S, Kawashima H, et al. Acute kidney injury in type 3 Bartter syndrome: angiotensin-converting enzyme inhibitors as a cause[J]. Pediatr Int, 2016, 58: 1373-1374. doi:  10.1111/ped.13100
    [62] Bell DS. Successful utilization of aliskiren, a direct renin inhibitor in Bartter syndrome[J]. South Med J, 2009, 102: 413-415. doi:  10.1097/SMJ.0b013e31819b8673
    [63] Seyberth HW, Schlingmann KP. Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects[J]. Pediatr Nephrol, 2011, 26: 1789-1802. doi:  10.1007/s00467-011-1871-4
    [64] Kontorinis G, Giesemann AM, Iliodromiti Z, et al. Treating hearing loss in patients with infantile Bartter syndrome[J]. Laryngoscope, 2012, 122: 2524-2528. doi:  10.1002/lary.23532
    [65] Schurman SJ, Perlman SA, Sutphen R, et al. Genotype/phenotype observations in African Americans with Bartter syndrome[J]. J Pediatr, 2001, 139: 105-110. doi:  10.1067/mpd.2001.115020
    [66] Wu X, Yang G, Chen S, et al. Bartter syndrome with long-term follow-up: a case report[J]. J Int Med Res, 2020, 48: 300060520947876.
    [67] Yang X, Zhang G, Wang M, et al. Bartter syndrome type 3: phenotype-genotype correlation and favorable response to ibuprofen[J]. Front Pediatr, 2018, 6: 153. doi:  10.3389/fped.2018.00153
    [68] Sardani Y, Qin K, Haas M, et al. Bartter syndrome complicated by immune complex nephropathy. Case report and literature review[J]. Pediatr Nephrol, 2003, 18: 913-918. doi:  10.1007/s00467-003-1194-1
    [69] Zhu B, Jiang H, Cao M, et al. A novel CLCNKB mutation in a Chinese girl with classic Bartter syndrome: a case report[J]. BMC Med Genet, 2019, 20: 137. doi:  10.1186/s12881-019-0869-9
    [70] Mrad FCC, Soares SBM, de Menezes Silva LAW, et al. Bartter's syndrome: clinical findings, genetic causes and therapeutic approach[J]. World J Pediatr, 2021, 17: 31-39. doi:  10.1007/s12519-020-00370-4
    [71] Landau D, Gurevich E, Sinai-Treiman L, et al. Accentua-ted hyperparathyroidism in type Ⅱ Bartter syndrome[J]. Pediatr Nephrol, 2016, 31: 1085-1090. doi:  10.1007/s00467-016-3337-1
    [72] Dickson FJ, Sayer JA. Nephrocalcinosis: a review of monogenic causes and insights they provide into this heterogeneous condition[J]. Int J Mol Sci, 2020, 21: 369. doi:  10.3390/ijms21010369
    [73] Devuyst O, Belge H, Konrad M, et al. Renal tubular disorders of electrolyte regulation in children[J]. Pediatr Nephrol, 2016, 38: 1246-1252.
    [74] Landau D, Shalev L, Schneider E, et al. Bartter syndrome types 2 and 4: complications in currently treated young adults[J]. Pediatr Nephrol, 2016: 1743-1744.
    [75] Saha A, Pande P, Vala K, et al. Clinical exome sequencing uncovers an unsuspected diagnosis of Bartter syndrome type 2 in a child with incidentally detected nephrocalcinosis[J]. CEN Case Rep, 2022, 11: 417-421. doi:  10.1007/s13730-022-00694-2
    [76] Tian M, Peng H, Bi X, et al. Late-onset Bartter syndrome type Ⅱ due to a novel compound heterozygous mutation in KCNJ1 gene: a case report and literature review[J]. Front Med, 2022, 9: 862514. doi:  10.3389/fmed.2022.862514
    [77] Sharma A, Linshaw MA. A novel compound heterozygous ROMK mutation presenting as late onset Bartter syndrome associated with nephrocalcinosis and elevated 1, 25(OH)(2) vitamin D levels[J]. Clin Exp Nephrol, 2011, 15: 572-576. doi:  10.1007/s10157-011-0431-3
    [78] Bettinelli A, Ciarmatori S, Cesareo L, et al. Phenotypic variability in Bartter syndrome type Ⅰ[J]. Pediatr Nephrol, 2000, 14: 940-945. doi:  10.1007/PL00013418
    [79] Hsu IR, Kamil ES, Lemley KV, et al. Syndrome of antenatal Bartter-like syndrome, hyperparathyroidism, hypercalcemia, bilateral nephrocalcinosis and nephrogenic DI in three patients treated with cinacalcet[J/OL ]. (2019-07-16)[2023-04-15]. https://doi.org/10.1093/edrv/35.supp.1.
    [80] Novo R, Cartigny M, Lefevre C, et al. Bartter syndrome with bone-destroying hyperparathyroidism: about two cases, genetically proved, with long-lasting follow-up[J]. Horm Res Paediatr, 2016, 86: 173.
    [81] Rodríguez-Soriano J, Vallo A, Aguirre M. Bone mineral density and bone turnover in patients with Bartter syndrome[J]. Pediatr Nephrol, 2005, 20: 1120-1125. doi:  10.1007/s00467-005-1901-1
    [82] Gross I, Siedner-Weintraub Y, Simckes A, et al. Antena-tal Bartter syndrome presenting as hyperparathyroidism with hypercalcemia and hypercalciuria: a case report and review[J]. J Pediatr Endocrinol Metab, 2015, 28: 943-946.
    [83] He Y, Zhou Y, Wu W, et al. Bartter syndrome with multiple renal and liver cysts: a case report[J]. Int Urol Nephrol, 2022, 55: 225-228. doi:  10.1007/s11255-022-03274-6
    [84] Lee SE, Han KH, Jung YH, et al. Renal transplantation in a patient with Bartter syndrome and glomerulosclerosis[J]. Korean J Pediatr, 2011, 54: 36. doi:  10.3345/kjp.2011.54.1.36
    [85] Cha EJ, Hwang WM, Yun SR, et al. An adult case of Bartter syndrome type Ⅲ presenting with proteinuria[J]. J Pathol Transl Med, 2016, 50: 160-164. doi:  10.4132/jptm.2015.08.31
    [86] Carmody JB, Charlton JR. Short-term gestation, long-term risk: prematurity and chronic kidney disease[J]. Pediatrics, 2013, 131: 1168-1179. doi:  10.1542/peds.2013-0009
    [87] Chong L, Baikunje S, Poller DN, et al. An unusual cause of acute renal failure with volume depletion due to renal losses[J]. Am J Kidney Dis, 2008, 52: 366-369. doi:  10.1053/j.ajkd.2008.04.025
    [88] Khosravi M, Walsh SB. The long-term complications of the inherited tubulopathies: an adult perspective[J]. Pediatr Nephrol, 2014, 30: 385-395.
    [89] Reinalter SC, Gröne HJ, Konrad M, et al. Evaluation of longterm treatment with indomethacin in hereditary hypokalemic salt-losing tubulopathies[J]. J Pediatr, 2001, 139: 398-406. doi:  10.1067/mpd.2001.117007
    [90] Altneida OD, Spinnato JA. Maternal Bartter's syndrome and pregnancy[J]. Am J Obstet Gynecol, 1989, 160: 1225-1226. doi:  10.1016/0002-9378(89)90198-1
    [91] Deruelle P, Dufour P, Magnenant E, et al. Maternal Bartter's syndrome in pregnancy treated by amiloride[J]. Eur J Obstet Gynecol Reprod Biol, 2004, 115: 106-107. doi:  10.1016/j.ejogrb.2004.01.030
    [92] O'Sullivan E, Monga M, Graves W. Bartter's syndrome in pregnancy: a case report and review[J]. Am J Perinatol, 1997, 14: 55-57. doi:  10.1055/s-2007-994097
    [93] Rigó J Jr, Gláz E, Papp Z. Low or high doses of spironolactone for treatment of maternal Bartter's syndrome[J]. Am J Obstet Gynecol, 1996, 174: 297.
    [94] Nohira TNT, Akutagawa O, Fujito A, et al. Pregnancy complicated with Bartter's syndrome: a case report[J]. J Obstet Gynaecol Res, 2001, 27: 267-274. doi:  10.1111/j.1447-0756.2001.tb01268.x
    [95] Luqman A, Kazmi A, Wall BM, et al. Bartter's syndrome in pregnancy: review of potassium homeostasis in gestation[J]. Am J Med Sci, 2009, 338: 500-504. doi:  10.1097/MAJ.0b013e31819f1ed8
    [96] Peregrin-Alvarez I, Rodriguez-Casares J, Lucena-Herrera C, et al. Bartter's syndrome and pregnancy[J]. Eur J Obstet Gynecol Reprod Biol, 2005, 121: 118-119. doi:  10.1016/j.ejogrb.2004.12.005
    [97] Zhang L, Peng X, Zhao B, et al. Clinical and laboratory features of female Gitelman syndrome and the pregnancy outcomes in a Chinese cohort[J]. Nephrology, 2020, 25: 749-757. doi:  10.1111/nep.13743
    [98] Kannan S, Delph Y, Moseley HS. Anaesthetic manage-ment of a child with Bartter's syndrome[J]. Can J Anaesth, 1995, 42: 808-812. doi:  10.1007/BF03011183
    [99] Raza D, Khan FA. Anaesthetic management for hiatal hernia repair in a child with Bartter's syndrome: A case report[J]. J Pak Med Assoc, 2020, 70: 737-739.
    [100] Roelofse JA, van der Westhuijzen AJ. Anesthetic management of a patient with Bartter's syndrome undergoing orthognathic surgery[J]. Anesth Prog, 1997, 44: 71-75.
    [101] Kim JY, Kim GA, Song JH, et al. A case of living-related kidney transplantation in Bartter's syndrome[J]. Yonsei Med J, 2000, 41: 662-665. doi:  10.3349/ymj.2000.41.5.662
    [102] Nooh N, Abdullah W, Sheta S. Anesthetic management of a patient with Bartter's syndrome undergoing bilateral sagittal split osteotomy[J]. Saudi J Anaesth, 2012, 6: 419-422. doi:  10.4103/1658-354X.105895
    [103] Fujino S, Miyoshi N, Ohue M, et al. Rectal cancer in a patient with Bartter syndrome: a case report[J]. Genes, 2017, 8: 139. doi:  10.3390/genes8050139
    [104] Gallagher H, Soar J, Tomson C. New guideline for perioperative management of people with inherited salt-wasting alkaloses[J]. Br J Anaesth, 2016, 116: 746-749. doi:  10.1093/bja/aew102
  • 加载中


    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(6)

    Article Metrics

    Article views (542) PDF downloads(519) Cited by()
    Proportional views


    DownLoad:  Full-Size Img  PowerPoint